Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL by Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D

Get full text